Danaher Corporation vs IDEXX Laboratories, Inc.
A head-to-head of Danaher Corporation (DHR) and IDEXX Laboratories, Inc. (IDXX) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | DHR | IDXX |
|---|---|---|
| Market Cap | $144.26B | $44.76B |
| P/E (TTM) | 39.43 | 43.38 |
| Forward P/E | 22.06 | 35.11 |
| P/S | 4.91 | 10.28 |
| P/B | 3.42 | 39.57 |
| EV/EBITDA | 17.11 | 30.20 |
| Dividend Yield | 0.50% | — |
| Profit Margin | 14.89% | 24.63% |
| Gross Margin | 59.11% | 61.80% |
| Operating Margin | 19.09% | 31.60% |
| Revenue Growth (YoY) | +3.66% | +14.26% |
| FCF Yield | 4.35% | 2.34% |
| Debt / Equity | 34.90 | 62.97 |
| Current Ratio | 1.87 | 1.12 |
Which is better: Danaher Corporation or IDEXX Laboratories, Inc.?
- ✓Larger by market cap: Danaher Corporation
- ✓Cheaper valuation (lower P/E): Danaher Corporation
- ✓More profitable (net margin): IDEXX Laboratories, Inc.
- ✓Faster revenue growth: IDEXX Laboratories, Inc.
- ✓Higher free-cash-flow yield: Danaher Corporation
Across 12 available metrics, Danaher Corporation leads 8–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.